266 related articles for article (PubMed ID: 3315593)
1. The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage.
Buchalter MB; Bourke JP; Jennings K; Adams PC; Kenmure AC; Hah CW; Reid DS
Drugs; 1987; 33 Suppl 3():209-15. PubMed ID: 3315593
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
3. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
[TBL] [Abstract][Full Text] [Related]
4. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin].
Cassagnes J; Bassand JP; Machecourt J; Lusson JR; Anguenot T; Borel E; Vacher D; Denis B; Maurat JP; Jallut H
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):453-60. PubMed ID: 2111665
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
[TBL] [Abstract][Full Text] [Related]
6. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
[TBL] [Abstract][Full Text] [Related]
7. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular function after anisoylated plasminogen streptokinase activator complex.
Been M; Muir AL; de Bono DP
Drugs; 1987; 33 Suppl 3():191-7. PubMed ID: 3315591
[TBL] [Abstract][Full Text] [Related]
9. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
Johnson ES; Cregeen RJ
Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
[TBL] [Abstract][Full Text] [Related]
10. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
Anderson JL
Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction.
Hogg KJ; Lees KR; Hornung RS; Howie CA; Dunn FG; Hillis WS
Br Heart J; 1989 Jun; 61(6):489-95. PubMed ID: 2667593
[TBL] [Abstract][Full Text] [Related]
12. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
Been M; de Bono DP; Muir AL; Boulton FE; Hillis WS; Hornung R
Br Heart J; 1985 Mar; 53(3):253-9. PubMed ID: 3882107
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
Bonnier JJ
Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
[TBL] [Abstract][Full Text] [Related]
14. Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hillis WS; Hornung RS; Hogg KJ; Hockings N; Burns JM; Dunn FG
Drugs; 1987; 33 Suppl 3():117-23. PubMed ID: 3315576
[TBL] [Abstract][Full Text] [Related]
15. Improved left ventricular function in myocardial infarction following intravenous thrombolytic therapy with acylated plasminogen activator.
Ovsyshcher I; Silber H; Hausman MI; Margolis G; Gueron M
Angiology; 1990 Feb; 41(2):133-8. PubMed ID: 2407157
[TBL] [Abstract][Full Text] [Related]
16. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
Brochier ML; Quilliet L; Kulbertus H; Materne P; Letac B; Cribier A; Monassier JP; Sacrez A; Favier JP
Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
[TBL] [Abstract][Full Text] [Related]
17. AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee.
Drugs; 1987; 33 Suppl 3():227-8. PubMed ID: 3315598
[No Abstract] [Full Text] [Related]
18. [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].
Doenecke P; Schwerdt H; Hellstern P; Wenzel E; Bette L
Klin Wochenschr; 1986 Aug; 64(15):682-7. PubMed ID: 3531704
[TBL] [Abstract][Full Text] [Related]
19. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
Bassand JP; Machecourt J; Cassagnes J; Anguenot T; Lusson R; Borel E; Peycelon P; Wolf E; Ducellier D
J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
[TBL] [Abstract][Full Text] [Related]
20. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
Julian DG; Borthwick LS; Reid D; Jennings KP; Wainwright RJ; Rodger JC; Wood D; Phillips WS
Drugs; 1987; 33 Suppl 3():261-7. PubMed ID: 3315604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
